Join RESI in beautiful PARIS for the 2nd annual RESI Europe! Mark your calendar because you will not want to miss this gathering of 200+ global early stage life science investors.

The Redefining Early Stage Investments (RESI) conference series was created by Life Science Nation (LSN) to bring together startups with early-stage investors and strategic channel partners. The goal of this series is to maximize the capability of these companies, from seed to series B, to find partners who are a fit for their technology and stage of development.  What‘s unique about RESI is that the event is cross-border and cross-domain, connecting startups with 10 categories of global investors across the silos of drugs, devices, diagnostics and digital health. RESI caters to both the earliest stage startups, those seeking grants, seed and angel capital, and the early-stage firms who seek series A and B funding.